Guideline-Discordant Care in Early-Stage Vulvar Cancer. Issue 6 (2nd December 2022)

• Record Type: Journal Article
• Authors: Bercow, Alexandra S.; Rauh-Hain, J. Alejandro; Melamed, Alexander; Mazina, Varvara; Growdon, Whitfield B.; del Carmen, Marcela G.; Goodman, Annekathryn; Bouberhan, Sara; Bregar, Amy; Eisenhauer, Eric L.; Molina, George; Minami, Christina
• Is Part Of: Obstetrics and gynecology. Volume 140:Issue 6(2022)
• Page Start: 1031
• Page End: 1041
• Publication Date: 2022-12-02
• Subjects: Obstetrics -- Periodicals; Gynecology -- Periodicals; 618
• DOI: 10.1097/AOG.0000000000004992
• Languages: English
• ISSNs: 0029-7844

Abstract

Abstract : Older age, Black race, and treatment at a low-volume hospital are associated with lower probability of undergoing guideline-concordant lymph node evaluation for early-stage vulvar cancer. Abstract : OBJECTIVE: To describe the use of National Comprehensive Cancer Network guideline-concordant inguinofemoral lymph node (LN) evaluation in individuals with early-stage vulvar cancer. METHODS: This retrospective cohort study identified patients with T1b and T2 vulvar squamous cell carcinoma diagnosed between 2012 and 2018 using the National Cancer Database. Factors associated with LN evaluation were examined using logistic regression analyses, adjusting for patient, disease, and facility-level characteristics. Kaplan-Meier survival analysis using log rank test and Cox regression was performed for the entire cohort and a subgroup of older patients, defined as individuals aged 80 years or older. RESULTS: Of the 5, 685 patients with vulvar cancer, 3, 756 (66.1%) underwent guideline-concordant LN evaluation. In our adjusted model, age 80 years or older (odds ratio [OR], 0.30; 95% CI 0.22–0.42) and Black race (OR 0.72; 95% CI 0.54–0.95) were associated with lower odds of LN evaluation. High-volume hospitals were associated with increased odds of LN evaluation compared with low-volume hospitals (OR 1.62; 95% CI 1.28–2.05). Older individuals who did not undergo LN evaluation had significantly worse overall survival than those with pathologically negative LNs (hazard ratio [HR] 0.45; 95% CI 0.37–0.55) and similar overall survival as those with pathologically positive LNs (HR 1.05; 95% CI 0.77–1.43). CONCLUSION: Guideline-concordant LN evaluation for early-stage vulvar squamous cell carcinoma is low. Lower utilization is associated with older age, Black race, and care at a low-volume hospital.